M/20/009 - Portlon (Parma)/ Hermitage [2020] IECompA m20009 (29 July 2020)

M/20/009 - Portlon (Parma)/ Hermitage [2020] IECompA m20009 (29 July 2020)

The Competition and Consumer Protection Commission determined that the proposed acquisition would not substantially lessen competition in the private healthcare sector.

Parties
Acquirer: Parma Investments Limited; Target: Hermitage Clinic Limited; Target: Hermitage Medical Developments Limited; Target: Torcross Limited
Jurisdiction
Ireland
Judgment Date
29 July 2020
Procedural Posture
Merger Control / Determination
Outcome
merger cleared
Legal Topics
Merger Clearance, Private Healthcare Sector

Case Brief

Summary, issues, holding and outcome

More case intelligence is available

Unlock the full research layer for this judgment.

Full judgment text Downloadable case file Legal principles 1 Authorities cited 1 Party arguments 2 Amounts and remedies 1
Sign in to unlock

Parties

Parma Investments Limited

Acquirer

Hermitage Clinic Limited

Target

Hermitage Medical Developments Limited

Target

Torcross Limited

Target

Procedural Posture

Merger Control / Determination

  1. 1 Whether the proposed acquisition would substantially lessen competition in the private healthcare sector

Ratio Decidendi

The Competition and Consumer Protection Commission determined that the proposed acquisition would not substantially lessen competition in the private healthcare sector.

Court Disposition

merger cleared

Orders

  • The proposed acquisition by Parma Investments Limited of sole control of Hermitage Clinic Limited, Hermitage Medical Developments Limited and Torcross Limited is cleared.